Source-grounded facts extracted from AVITA Medical, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Jan Stern Reed was appointed as Chair of the Board at AVITA Medical, Inc..
“the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025”
Cary Vance was appointed as President and Chief Executive Officer at AVITA Medical, Inc..
“the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026”
AVITA Medical, Inc. terminated Existing Credit Agreement with Lender under existing facility (effective 2026-01-13).
“Simultaneously with the closing of the Initial Commitment Amount, the Company repaid in full and terminated all of its obligations and commitments (the “Refinancing Transaction”) under the Existing Credit Agreement (as defined below).”
AVITA Medical, Inc. entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at $60 million (effective 2026-01-13).
“On January 13, 2026 (the “Closing Date”), AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), by and among the Company, as borrower, Avita Medical Americas, LLC, a wholly-owned subsidiary of the Company, as guarantor (the “Guarantor,” taken together with the Company, the “Obligors”) and Perceptive Credit Holdings V, LP as a lender and the administrative agent (the “Lender,” and the “Administrative Agent,” as applicable).”
AVITA Medical, Inc. incurred credit facility of up to $60 million with Perceptive Credit Holdings V, LP at greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case, maturing five-year senior secured credit facility.
“Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $60 million”
Nicole Kelsey was appointed as Chief Legal and Compliance Officer and Corporate Secretary at AVITA Medical, Inc..
“Ms. Shiroma is succeeded by Nicole Kelsey, effective immediately, who will serve as the Company’s Chief Legal and Compliance Officer and Corporate Secretary.”
Donna Shiroma retired as General Counsel, Compliance Officer and Corporate Secretary at AVITA Medical, Inc..
“On June 28, 2024, Ms. Donna Shiroma, the Company’s General Counsel, Compliance Officer and Corporate Secretary, notified AVITA Medical, Inc. (the "Company") of her retirement effective immediately.”
AVITA Medical, Inc. updated its first quarter ended March 31, 2024 guidance (lowered).
“On May 13, 2024, AVITA Medical, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.